H.C. Wainwright raises Tango Therapeutics price target to $68
What it means
- What to watch: $TNGX got a new price target near $68; the reasoning behind it says more than the number does.
- How the stock is trading: $TNGX +6.48% in the latest session.
- Timing: It landed before the opening bell — early risers had it with their coffee, and the next session was the first that could react.
Where the stock stands
$TNGX last traded at $23.17, +6.48% on the session. That puts it 33% shy of its 52-week high of $34.39 and 214% clear of its low of $7.37 — a little above the middle of the range. Over the year it has ranged 367% from low to high: a very wide band; big swings are routine for this one, not news. These are latest-session quotes, not live prices — the live tape is on the $TNGX page.
How much coverage it is getting
In the last 30 days Wook has filed 2 stories about $TNGX — 0 of them this week. None arrived this week, so the run has gone quiet. Across those stories 0 read bullish, 2 neutral and 0 bearish. This one reads neutral, so it sits in step with most of the run. 2 of the 2 (100%) came from Investing.com itself, so the count says as much about how often Investing.com hits publish as about how much attention there is — the other outlets are the better gauge. 12 related stories — same name or same desk — are lined up beside this one if you want the whole thread.
The bigger picture
Healthcare stories turn on approvals, trial data and pricing: one FDA decision or trial readout can swing a single drugmaker hard, while drug-pricing policy moves the whole group at once. Wook's supply-chain scanner has Health Care reading calm today: no unusual stress in the filings and disclosures it watches.
What to watch next
The $TNGX page has the full chart, the filings and the valuation model behind every figure here. Because one outlet dominates the coverage, reading another outlet on the same story is the quickest check on whether it is being confirmed or just repeated. Wook AI, above, can pull live figures and run the numbers on request — how far $TNGX is from its high, or how this week's coverage compares.
How this analysis was made
Investing.com published it, and Wook filed it under Healthcare & Pharma. No strongly worded term either way, so it reads neutral at low severity — a factual headline rather than a charged one. It was matched to $TNGX. It carried $68, shown as published and not recalculated. The publisher gave no preview text, and nothing has been written in to fill the gap.
The tone and severity labels come from a fixed word list — no editor, no AI, no crystal ball — so they describe how a story is worded, not what happens next. They are not a forecast or a recommendation, and a same-day move does not mean this story caused it. Not investment advice.
Discussion
No one has weighed in yet. Start the discussion on this story.
What happened after this published
Investing.com published this on August 18, 2026. $TNGX has moved -8.92% ($25.44 to $23.17). Measured from the first print available after publication, against the latest available quote. This comparison does not isolate the story's effect.